Title:
【発明の名称】乾癬治療のための組成物
Document Type and Number:
Japanese Patent JP2510675
Kind Code:
B2
Abstract:
Disclosed are methods and compositions employing azidothymidine for the treatment of psoriasis. Oral, parenteral or topical dosage forms are administered to affected individuals in therapeutically effective amounts. Typically, between about 100 and about 4000 mg of azidothymidine is administered orally per day until symptoms of the disease such as inflammation, irritation, or incidence or size of lesions, are abated. Also disclosed are topical dosage forms, including pharmaceutically acceptable creams, lotions, ointments, salves and the like, which include therapeutically effective concentrations of azidothymidine. Such topical compositions may further include effective amounts of a corticosteroid or a cutaneous surface acting anti-psoriatic agent, such as a keratolytic agent.
Inventors:
MADOREIN DEYUBI
GEERII DABURYU BURUUTON
GEERII DABURYU BURUUTON
Application Number:
JP14272988A
Publication Date:
June 26, 1996
Filing Date:
June 09, 1988
Export Citation:
Assignee:
YUNIBAASHITEI OBU TEKISASU SHISUTEMU ZA
International Classes:
A61K31/05; A61K31/12; C07H19/073; A61K31/57; A61K31/70; A61K31/7042; A61K31/7052; A61K31/7064; A61K31/7072; A61K33/04; A61K35/04; A61P31/04; A61P43/00; C07H19/06; (IPC1-7): A61K31/70
Domestic Patent References:
| JP63290894A |
Attorney, Agent or Firm:
Kazuo Sato (2 outside)